These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30755733)

  • 1. Base excision repair regulates PD-L1 expression in cancer cells.
    Permata TBM; Hagiwara Y; Sato H; Yasuhara T; Oike T; Gondhowiardjo S; Held KD; Nakano T; Shibata A
    Oncogene; 2019 Jun; 38(23):4452-4466. PubMed ID: 30755733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells.
    Sato H; Niimi A; Yasuhara T; Permata TBM; Hagiwara Y; Isono M; Nuryadi E; Sekine R; Oike T; Kakoti S; Yoshimoto Y; Held KD; Suzuki Y; Kono K; Miyagawa K; Nakano T; Shibata A
    Nat Commun; 2017 Nov; 8(1):1751. PubMed ID: 29170499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response and PD-1/PD-L1 pathway in ovarian cancer.
    Zhang T; Zheng S; Liu Y; Li X; Wu J; Sun Y; Liu G
    DNA Repair (Amst); 2021 Jun; 102():103112. PubMed ID: 33838550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells.
    Chan N; Ali M; McCallum GP; Kumareswaran R; Koritzinsky M; Wouters BG; Wells PG; Gallinger S; Bristow RG
    Mol Cancer Res; 2014 Oct; 12(10):1407-15. PubMed ID: 25030372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.
    Van Der Kraak L; Goel G; Ramanan K; Kaltenmeier C; Zhang L; Normolle DP; Freeman GJ; Tang D; Nason KS; Davison JM; Luketich JD; Dhupar R; Lotze MT
    J Immunother Cancer; 2016; 4():65. PubMed ID: 27777774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade.
    Wang Z; Zhao J; Wang G; Zhang F; Zhang Z; Zhang F; Zhang Y; Dong H; Zhao X; Duan J; Bai H; Tian Y; Wan R; Han M; Cao Y; Xiong L; Liu L; Wang S; Cai S; Mok TSK; Wang J
    Cancer Res; 2018 Nov; 78(22):6486-6496. PubMed ID: 30171052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.
    Chaganty BKR; Qiu S; Gest A; Lu Y; Ivan C; Calin GA; Weiner LM; Fan Z
    Cancer Lett; 2018 Aug; 430():47-56. PubMed ID: 29746929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
    Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage.
    Hagiwara Y; Sato H; Permata TBM; Niimi A; Yamauchi M; Oike T; Nakano T; Shibata A
    Hum Immunol; 2018 Aug; 79(8):627-631. PubMed ID: 29859207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
    Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
    PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.
    Cheon H; Holvey-Bates EG; McGrail DJ; Stark GR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34799452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation.
    Mouw KW; Konstantinopoulos PA
    Br J Cancer; 2018 Apr; 118(7):933-935. PubMed ID: 29531322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.
    Martin AM; Nirschl TR; Nirschl CJ; Francica BJ; Kochel CM; van Bokhoven A; Meeker AK; Lucia MS; Anders RA; DeMarzo AM; Drake CG
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):325-32. PubMed ID: 26260996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
    Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
    Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers.
    Green AR; Aleskandarany MA; Ali R; Hodgson EG; Atabani S; De Souza K; Rakha EA; Ellis IO; Madhusudan S
    Cancer Immunol Res; 2017 Apr; 5(4):292-299. PubMed ID: 28254786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function.
    Ahn HK; Kim S; Kwon D; Koh J; Kim YA; Kim K; Chung DH; Jeon YK
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil-DNA glycosylase after oxidative stress.
    Akbari M; Otterlei M; Peña-Diaz J; Krokan HE
    Neuroscience; 2007 Apr; 145(4):1201-12. PubMed ID: 17101234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
    Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
    Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Chou WC; Hu LY; Hsiung CN; Shen CY
    Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.